Dargle Holdings Ltd 12998718 false 2022-12-01 2023-11-30 2023-11-30 The principal activity of the company is research and experimental development on biotechnology. Digita Accounts Production Advanced 6.30.9574.0 true 12998718 2022-12-01 2023-11-30 12998718 2023-11-30 12998718 bus:Director1 1 2023-11-30 12998718 core:CurrentFinancialInstruments core:WithinOneYear 2023-11-30 12998718 bus:Micro-entities 2022-12-01 2023-11-30 12998718 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 12998718 bus:FilletedAccounts 2022-12-01 2023-11-30 12998718 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 12998718 bus:RegisteredOffice 2022-12-01 2023-11-30 12998718 bus:Director1 2022-12-01 2023-11-30 12998718 bus:Director1 1 2022-12-01 2023-11-30 12998718 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 12998718 countries:EnglandWales 2022-12-01 2023-11-30 12998718 bus:Director1 1 2022-11-30 12998718 2021-12-01 2022-11-30 12998718 2022-11-30 12998718 core:CurrentFinancialInstruments core:WithinOneYear 2022-11-30 iso4217:GBP xbrli:pure

Registration number: 12998718

Dargle Holdings Ltd

Unaudited Filleted Financial Statements

for the Year Ended 30 November 2023

 

Dargle Holdings Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Dargle Holdings Ltd

Company Information

Director

Dr E Sullivan

Registered office

20-22 Wenlock Road
London
N1 7GU

Accountants

RWB CA Limited
Northgate House
North Gate
New Basford
Nottingham
NG7 7BQ

 

Dargle Holdings Ltd

(Registration number: 12998718)
Balance Sheet as at 30 November 2023

2023
£

2022
£

Fixed assets

484

714

Current assets

198,132

211,969

Creditors: Amounts falling due within one year

(31,925)

(36,585)

Net current assets

166,207

175,384

Total assets less current liabilities

166,691

176,098

Accruals and deferred income

(750)

(10,050)

 

165,941

166,048

Capital and reserves

165,941

166,048

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
20-22 Wenlock Road
London
N1 7GU

These financial statements were authorised for issue by the director on 29 August 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).

3

Related party transactions

Transactions with the director

2023

At 1 December 2022
£

At 30 November 2023
£

Dr E Sullivan

-

24,359

 

Dargle Holdings Ltd

(Registration number: 12998718)
Balance Sheet as at 30 November 2023

For the financial year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 29 August 2024
 

.........................................
Dr E Sullivan
Director